STOCK TITAN

Alamar Biosciences (ALMR) president reports Class B stake and option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Alamar Biosciences, Inc. President Timothy Ogden White filed an initial ownership report showing direct holdings of 454,583 shares of Class B Common Stock. He also reports multiple stock options to buy Class B Common Stock, with exercise prices ranging from $0.59 to $7.60 per share and expirations between 2031 and 2036, many vesting in equal monthly installments over 48 months, subject to his continuous service.

Positive

  • None.

Negative

  • None.
Insider White Timothy Ogden
Role President
Type Security Shares Price Value
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Class B Common Stock -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 29,357 shares (Direct, null); Class B Common Stock — 454,583 shares (Direct, null)
Footnotes (1)
  1. Fully vested. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date. The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date. Twenty-five percent of the shares subject to the option vest on January 1, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date.
Direct Class B Common Stock holdings 454,583 shares Beneficial ownership reported by President Timothy Ogden White
Option exercise price (highest) $7.60 per share Stock Option (Right to Buy) expiring 2036-01-14
Option exercise price (lowest) $0.59 per share Stock Option (Right to Buy) expiring 2031-04-20
Underlying shares at $7.60 16,333 shares Stock Option (Right to Buy) on Class B Common Stock
Largest option grant 206,782 underlying shares Stock Option (Right to Buy) at $3.34 exercise price
Intermediate option grant 29,357 underlying shares Stock Option (Right to Buy) at $0.59 exercise price
Class B Common Stock financial
"security_title: "Class B Common Stock""
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Stock Option (Right to Buy financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
""conversion_or_exercise_price": "7.6000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
""expiration_date": "2036-01-14T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
continuous service financial
"subject to the reporting person's continuous service as of each such vesting date"
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
White Timothy Ogden

(Last)(First)(Middle)
C/O ALAMAR BIOSCIENCES, INC.
47071 BAYSIDE PARKWAY

(Street)
FREMONT CALIFORNIA 94538

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/16/2026
3. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class B Common Stock454,583D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy) (1)04/20/2031Class B Common Stock29,357$0.59D
Stock Option (Right to Buy) (1)02/15/2032Class B Common Stock8,726$2.28D
Stock Option (Right to Buy) (2)04/16/2034Class B Common Stock10,686$3.34D
Stock Option (Right to Buy) (3)01/15/2035Class B Common Stock206,782$3.34D
Stock Option (Right to Buy) (4)01/15/2035Class B Common Stock8,532$3.34D
Stock Option (Right to Buy) (5)04/08/2035Class B Common Stock5,775$3.1D
Stock Option (Right to Buy) (6)01/14/2036Class B Common Stock16,333$7.6D
Explanation of Responses:
1. Fully vested.
2. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date.
3. The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date.
4. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date.
5. Twenty-five percent of the shares subject to the option vest on January 1, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.
6. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date.
/s/ Justin J. McAnear, Attorney-in-Fact04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Timothy Ogden White’s Form 3 filing for Alamar Biosciences (ALMR) show?

The Form 3 shows that President Timothy Ogden White beneficially owns 454,583 shares of Class B Common Stock and several stock option grants. These options allow future purchases of Class B shares at preset prices, subject to vesting and continued service conditions.

How many Alamar Biosciences (ALMR) shares does Timothy Ogden White directly hold?

Timothy Ogden White directly holds 454,583 shares of Alamar Biosciences Class B Common Stock. This figure reflects his reported beneficial ownership as of the Form 3 date and provides a baseline view of his equity stake in the company.

What stock options are reported for Timothy Ogden White in the ALMR Form 3?

The filing lists multiple stock options to buy Class B Common Stock, including grants over 16,333, 206,782 and other share amounts. Exercise prices range from $0.59 to $7.60 per share, with expirations between 2031 and 2036, all reported as directly owned.

How do Timothy Ogden White’s Alamar Biosciences (ALMR) options vest?

Footnotes explain that several option grants vest in equal monthly installments over 48 months from specific start dates, such as January 1, 2024 and January 16, 2025. Vesting is contingent on his continuous service on each applicable vesting date.

Does the ALMR Form 3 indicate recent buying or selling by Timothy Ogden White?

The Form 3 is an initial ownership report and primarily lists existing holdings and option awards. The transaction summary shows no categorized buys or sells, only holding entries, so it does not highlight recent open-market purchases or sales.

What is the highest exercise price on Timothy Ogden White’s ALMR stock options?

One of Timothy Ogden White’s option grants carries an exercise price of $7.60 per share and is scheduled to expire in 2036. Other options have lower exercise prices, including $3.34, $3.10, $2.28 and $0.59 per share, with varying expiration dates.